Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

 
Web www.patentalert.com

< Mutant human factor IX with an increased resistance to inhibition by heparin

< Aliphatic compounds, their synthesis method, and utilization of the same

> Moving magnet actuator for providing haptic feedback

> Method and apparatus for controlling force feedback interface systems utilizing a host computer

~ 00254